Patient Advocacy Committee

The Mission

It is the purpose of BioNJ’s Patient Advocacy Committee to publicly raise awareness, educate and support the community regarding Patient Advocacy and its important role in partnership with industry. This Committee communicates that New Jersey’s biotech industry is a critical and long-term agent in the advancement of human health.

The Vision

Patient Advocacy is an accepted and vital company function that ensures patient community partnership in the development of and access to drugs and devices produced by the New Jersey biotechnology industry. BioNJ and its Patient Advocacy Committee remain dedicated to reaching this vision Because Patients Can’t Wait.

Committee Members

Jennifer McGarry, LLS
Janet Haag,
NAMI
Stephen Habbe,
American Diabetes Association
Eric Joice,
Family Resource Network
Liza Gundell,
Family Resource Network
Peter Ruccione,
American Diabetes Association
Lisa Schill,
Rasopathies Network
Dr. Robert Goldberg,
Center for Medicine in the Public Interest
Kim Roemer,
Multiple System Atrophy
Mary Francis Harmon,
PTC Therapeutics
Greg Geissman,
Celgene
Jayne Gershkowitz,
Amicus
Candi Phipps,
Novartis
Susan Gorky,
Celgene
Candie Phipps,
Novartis
Wendy M. Lazarus,
Pfizer
Dmitri Siegel,
Celgene
Cara Kelly,
Celgene
Jaye Bea Smalley,
Celgene
David Lustig,
Celgene
Lauren Wood,
Immunomedics